Definium Therapeutics (DFTX) Exchange Rate Effect (2021 - 2026)
Definium Therapeutics (DFTX) reported Exchange Rate Effect of $3000.0 for Q1 2026, up 125.0% year-over-year from $1333.3 in Q1 2025, and up 200.0% quarter-over-quarter from $1000.0 in Q4 2025.
Definium Therapeutics (DFTX) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 6 years of Exchange Rate Effect data on file, last reported at $3000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $3000.0, up 125.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $8000.0 (up 138.1% YoY), and the FY2025 annual result was -$7000.0, up 76.67% from the prior year.
- Exchange Rate Effect climbed to $3000.0 in Q1 2026 per DFTX's latest filing, from $1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $57000.0 in Q2 2023 and troughed at -$194000.0 in Q2 2022.
- A 5-year average of -$15529.4 and a median of $1000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect plunged 240.0% in 2024, then soared 2400.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $56000.0 in 2022, then slumped by 144.64% to -$25000.0 in 2023, then surged by 104.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025, then jumped by 200.0% to $3000.0 in 2026.
- Business Quant data shows DFTX's Exchange Rate Effect at $3000.0 in Q1 2026, $1000.0 in Q4 2025, and -$21000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Mar 31, 2025 | -12,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Dec 31, 2023 | -25,000.00 |